Connect with us

Market

Clean Power Solutions Take Aim At New Markets; Pacific Green Technologies Inc (PGTK), Plug Power Inc (PLUG), Liberty Star Uranium & Metals Corp. (LBSR)

Published

on

According to the IEA’s annual market report, renewable energy will be the largest source of electricity up to 2020 because of falling costs as well as eagerness to fight climate change. The report states that there is great promise within renewables because of their affordability, energy security, and positive impact on the environment. Here is what IEA’s Executive Director, Faith Birol, had to say: “Renewables are poised to seize the crucial top spot in global power supply growth, but this is hardly time for complacency.”

Pacific Green Technologies Inc (OTCMKTS:PGTK) has been hard at work trying to be a part of a future that is eco-friendly. The company has developed unique emission control technologies as a solution to the Earth’s need for healthier and more sustainable energy. Pacific Green Technologies Inc. also develops Renewable Power Plants though its unique Emissions Control Technology and licenses ENVI-Clean and ENVI-Pure, patented emissions control technologies.

On December 1st, Pacific Green Technologies Inc. reported that it signed a commercial joint venture agreement with POWERCHINA SPEM Co., Ltd. in order to sell its techonolgy to people in China. POWERCHINA SPEM is one of the biggest Chinese power equipment manufacturers and is a subsidiary of POWER CHINA, the leader in power plant equipment manufacturing in the People’s Republic of China (“PRC”). Chief Executive of PGTC, Alex Shead, said: “With the scale of POWERCHINA’s reach and capabilities as one of China’s leading State owned Enterprises, we are convinced that PGT’s technology will become the preeminent emissions control technology in China.”

This has definitely proven to be great news for Pacific Green Technologies Inc (OTCMKTS:PGTK). On December 1st, PGTK was trading sideways at a price of $0.3 and a volume of zero. Since that time, the stock has grown 83.33% to a high of $0.55. In addition, the stock traded with a volume of approximately 18,500 on December 7th. The press release definitely was beneficial for the company. This is not a surprise considering that it was, after all, great news.

Market

Eanings Review: Rambus Inc. (NASDAQ:RMBS), Revlon Inc (NYSE:REV)

Published

on

By

Revlon Inc(NYSE:REV) +2.5% after-hours after announcing that President and CEO Fabian Garcia is stepping down “to pursue other opportunities,” and Executive Vice Chair Paul Meister will oversee operations on an interim basis.

REV also says it expects Q4 revenues of $785M, below $801M from the year-earlier quarter but ahead of analyst consensus estimate of $743M, and a $60M-$80M net loss for the quarter due to a charge related to the recent tax law changes.

REV expects Q4 adjusted EBITDA of $110M-$115M vs. $115M analyst consensus.

CFO Chris Peterson also denies rumors that the company is considering a material asset transfer that would shield assets from lenders.

Rambus Inc.(NASDAQ:RMBS) shares are down 5.5% aftermarket following Q4 results that beat revenue estimates and met on EPS. In-line Q1 guidance (under ASC 605 accounting change) has revenue from $94M to $100M (consensus: $100.38M) and EPS from $0.17 to $0.23 (consensus: $0.18).

Revenue breakdown: Royalties, $77.9M (+10% Y/Y); Product, $8.5M (-27%); Contract and other revenue, $15.5M (+2%); Licensing billings, $76.6M (+18%).Key metrics: Non-GAAP operating margin, 31%; total operating expenses, $67.5M; cash and equivalents, $172.2M; cash flow from operations, $33.3M.

Continue Reading

Market

ADTRAN, Inc. (NASDAQ:ADTN) Hits New Lows After Issuing disappointing Earnings Forecast

Published

on

By

ADTRAN, Inc.(NASDAQ:ADTN) slumped to a 52-week low after forecasting below consensus guidance for Q4, revising its revenue estimate downward  to $125M from $155M-$165M earlier and seeing EPS of ~$0.01; analysts had expected EPS of ~$0.14 and revenue of $161.2M.

ADTN also projects Q1 to come in at roughly the same as Q4, misses analyst consensus of $167.5M.

CEO Tom Stanton says Q4 results have been hurt by a merger-related review, which ADTN expects to be completed in 60-90 days, and slowdown in the spending at a domestic Tier 1 customer.

MKM Partners analyst Michael Genovese believes the customer is CenturyLink (CTL -2%), which accounted for 24% of ADTN’s total sales in 2016.

The analyst thinks the weakness should prove temporary, adding that ADTN’s performance likely will accelerate into 2019 as the company stands to benefit from 5G spending; MKM trims its ADTN target price to $25 from $27 but keeps its Buy rating.

Continue Reading

Market

Big IPO Coming: Celator Pharmaceuticals Inc(NASDAQ:CPXX), Moleculin Biotech’s (MBRX)

Published

on

By

Today at 10am Eastern, Moleculin Biotech ticker symbol MBRX will debut on the Nasdaq stock exchange and is being considered as one of the most highly anticipated IPO’s of 2016 by the street. The excitement and anticipation is arising from many experts saying that Moleculin Biotech’s (MBRX) drug annamycin is far superior to Celator Pharmaceuticals Inc(NASDAQ:CPXX) drug daunorubicin.

CPXX which has been bought out by Jazz Pharmaceuticals plc – Ordinary Shares(NASDAQ:JAZZ) for $1.5 Billion Dollars last week, share price ran from $1.6 to $31 in 2 months. Moleculin Biotech’s share structure is a 1.5m public float Priced at $6.

Continue Reading
Advertisement

Trending